Access disconnection systems
    11.
    发明公开
    Access disconnection systems 有权
    SYSTEME ZUMLÖSENEINESGEFÄSSZUGANGS

    公开(公告)号:EP2253344A2

    公开(公告)日:2010-11-24

    申请号:EP10075380.5

    申请日:2003-04-02

    IPC分类号: A61M1/36 A61B5/00

    摘要: Apparatuses, devices, systems and methods for detecting access disconnection during medical therapy are provided. The present invention includes an electric circuit coupled to, for example, a blood circuit used during dialysis therapy. The electric circuit can be adapted to inject an electrical signal into the blood circuit such that changes in an electrical valve in response to access disconnection, such as needle drop-out or catheter drop-out, can be effectively detected.

    摘要翻译: 提供了用于在药物治疗期间检测进入断开的装置,装置,系统和方法。 本发明包括耦合到例如在透析治疗期间使用的血液回路的电路。 电路可以适于将电信号注入到血液回路中,使得能够有效地检测响应于诸如针脱出或导管脱出的入口断开的电气阀的变化。

    SURFACTANT COMPOSITION
    14.
    发明公开
    SURFACTANT COMPOSITION 有权
    含表面活性剂多肽复合物

    公开(公告)号:EP2538960A1

    公开(公告)日:2013-01-02

    申请号:EP11746932.0

    申请日:2011-02-25

    摘要: The disclosure describes a composition comprising a lipidaceous carrier and a peptide complex formed from poly-L-lysine or a salt thereof; and either poly-L-glutamic acid or poly-L-aspartic acid, or a salt thereof. The composition can be used to prevent or treat a disease related to pulmonary surfactant dysfunction, such as hyaline membrane disease (HMD), respiratory distress syndrome (RDS), hydrocarbon poisoning, near-drowning, HIV/AIDS-related lung diseases, adult respiratory distress syndrome (ARDS), asthma, tuberculosis (TB) or severe acute respiratory syndrome (SARS). Alternatively, the composition can be used to increase the permeability of a pharmaceutical compound or composition across a membrane of a subject. The poly-L-lysine or salt thereof is longer than the poly-L-glutamic acid or poly-L-aspartic acid so that the complex that forms has a charge-neutralised region and a positively-charged region. The charge-neutralised region of the peptide complex interacts with the lipidaceous carrier, while the positively-charged region interacts with an aqueous and/or polar environment.

    VIAL ACCESS SPIKE ASSEMBLY
    19.
    发明公开
    VIAL ACCESS SPIKE ASSEMBLY 有权
    SPIKE安排访问瓶

    公开(公告)号:EP2361076A1

    公开(公告)日:2011-08-31

    申请号:EP09764140.1

    申请日:2009-11-24

    IPC分类号: A61J1/20

    摘要: A spike assembly having an elongate spike defining a hollow cannula that is in fluid communication with the interior of a liter connection portion. The spike assembly provides needleless access to a stopper of a vial to facilitate injection and withdrawal of fluids via a syringe barrel selectively secured to the luer connection portion. The syringe can safely be removed from the spike assembly and then be directly attached to a luer compatible connector. The elongate spike may include a frangible tip portion that can break away from the spike assembly within a vial. The spike assembly may have a neck with a pair of gripping wing members. The spike assembly may have a feature that prevents rotation of the spike in the vial stopper, thereby allowing the syringe to be easily and safely disconnected from the spike assembly without having to grasp the spike assembly.

    Bicarbonate-based solutions for dialysis therapies
    20.
    发明公开
    Bicarbonate-based solutions for dialysis therapies 有权
    Lösungenenthaltend Bikarbonat毛皮Dialysetherapie

    公开(公告)号:EP2322236A1

    公开(公告)日:2011-05-18

    申请号:EP10075490.2

    申请日:2002-11-04

    IPC分类号: A61M1/28 A61K33/14 A61P13/12

    CPC分类号: A61K33/14

    摘要: Bicarbonate containing solutions for use during medical treatment are provided. The bicarbonate containing solution of the present invention includes at least two separate components including a bicarbonate concentrate and an electrolyte concentrate which can be readily and sterilely mixed to form a ready-to-use formulation for patient administration, particularly as applied to the treatment of acute renal failure associated with critically ill patients in an intensive care setting.

    摘要翻译: 提供了在医疗中使用的含碳酸氢盐溶液。 本发明的含碳酸氢盐溶液包括至少两种分离的组分,包括碳酸氢盐浓缩物和电解质浓缩物,其可以容易地和无菌地混合以形成用于患者给药的即用型制剂,特别是用于治疗急性 重症监护病房与危重病人相关的肾衰竭。